Relapsed/Refractory Multiple Myeloma and CAR T-Cell Therapy: Navigating the Patient Journey

Keeping Current - A podcast by Medscape Podcasts

Maybe CAR T-cell therapy is the treatment of choice for your patient with triple-class refractory multiple myeloma? Join the discussion now! Credit available for this activity expires: 3/23/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/970643?src=mkm_podcast_addon_970643